Compared with SDNs of p-LUAD, p-LUSC demonstrated elevated positivity for CYFRA 21-1, which was a soluble cytokeratin 19 fragment expressed in bronchial epithelium and related malignancies, released during cell degradation, and thus represents a useful serum tumor marker. Here, KRT19 is linked to neoplasm.